Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 09:58, 20 April 2011 (Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

SQ109

Names
IUPAC name N-Adamantan-2-yl-N'-((E)-3,7-dimethyl-octa-2,6-dienyl)-ethane-1,2-diamine
Identifiers
3D model (JSmol)	Interactive image
PubChem CID	5274428
CompTox Dashboard (EPA)	DTXSID30964540
SMILES CC(=CCC/C(=C/CNCCN1C2CC3CC(C2)CC1C3)/C)C
Properties
Chemical formula	C22H38N2
Molar mass	330.560 g·mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is  ?) Infobox references

SQ109 is a drug undergoing development for treatment of tuberculosis. On October 16th, 2007, it was given the status of Orphan drug by the USFDA for use against drug-susceptible and drug-resistant TB bacteria.

See also

• Adamantane
• Ethambutol

References

1. PMID 15644871
2. PMID 19362471

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Tuberculosis
• Adamantanes
• Antiinfective agent stubs